Chenguang Biotech Group Net Asset Momentum
Chenguang Biotech Group net asset momentum. Chenguang Biotech Group (300138) recorded a net asset momentum of 9.0% as of December 2025, with net assets of CN¥3.44 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore 300138 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Chenguang Biotech Group (2007–2025)
Net asset momentum of Chenguang Biotech Group from 2007 to 2025. This chart tracks Chenguang Biotech Group's year-over-year net asset growth across 19 annual reporting periods from 2007 to 2025. The most recent momentum reading is +9.0%, with net assets of CN¥3.44 Billion CNY as of December 2025. See 300138 total equity for net asset value and shareholders' equity analysis.
Chenguang Biotech Group Net Asset Momentum by Year (2007–2025)
Chenguang Biotech Group net asset momentum by year from 2007 to 2025. The table below shows the complete annual net asset history for Chenguang Biotech Group from 2007 to 2025, covering 19 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see market cap of Chenguang Biotech Group.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥3.44 Billion | CN¥9.50 Billion | CN¥6.07 Billion | ▲ +9.0% |
| 2024 | CN¥3.15 Billion | CN¥9.02 Billion | CN¥5.87 Billion | ▼ -10.7% |
| 2023 | CN¥3.53 Billion | CN¥8.54 Billion | CN¥5.01 Billion | ▲ +9.9% |
| 2022 | CN¥3.21 Billion | CN¥6.92 Billion | CN¥3.71 Billion | ▲ +15.5% |
| 2021 | CN¥2.78 Billion | CN¥5.96 Billion | CN¥3.17 Billion | ▲ +35.1% |
| 2020 | CN¥2.06 Billion | CN¥4.65 Billion | CN¥2.59 Billion | ▲ +18.3% |
| 2019 | CN¥1.74 Billion | CN¥4.51 Billion | CN¥2.77 Billion | ▲ +0.1% |
| 2018 | CN¥1.74 Billion | CN¥3.36 Billion | CN¥1.62 Billion | ▲ +7.2% |
| 2017 | CN¥1.62 Billion | CN¥2.87 Billion | CN¥1.25 Billion | ▲ +6.5% |
| 2016 | CN¥1.52 Billion | CN¥2.49 Billion | CN¥967.46 Million | ▲ +6.9% |
| 2015 | CN¥1.43 Billion | CN¥1.99 Billion | CN¥564.12 Million | ▲ +41.5% |
| 2014 | CN¥1.01 Billion | CN¥1.51 Billion | CN¥499.69 Million | ▲ +1.8% |
| 2013 | CN¥990.39 Million | CN¥1.63 Billion | CN¥641.26 Million | ▼ -0.7% |
| 2012 | CN¥997.86 Million | CN¥1.45 Billion | CN¥447.73 Million | ▲ +3.0% |
| 2011 | CN¥968.71 Million | CN¥1.12 Billion | CN¥147.16 Million | ▲ +3.8% |
| 2010 | CN¥933.05 Million | CN¥1.15 Billion | CN¥215.92 Million | ▲ +342.9% |
| 2009 | CN¥210.67 Million | CN¥402.85 Million | CN¥192.17 Million | ▲ +42.4% |
| 2008 | CN¥147.93 Million | CN¥385.24 Million | CN¥237.31 Million | ▲ +45.5% |
| 2007 | CN¥101.70 Million | CN¥187.20 Million | CN¥85.49 Million | — |